compounding glp-1 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Hims Inc. - Hims &

Emerging evidence suggests that GLP-1 RAs may be linked to increased gastric residual content (GRC), aspiration pneumonia, and aborted esophagogastroduodenoscopy (EGD) procedures

Those who have kidney disease

The uncoupling of Mitochondria-ER Contact Sites (MERCS) represents a hallmark of metabolic dysfunction in obesity and type 2 diabetes

News Coverage The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade

Retatrutide targets GLP-1, GIP & glucagon receptors

Each pack has 4 accurately dosed single use pre filled syringe along with 4 low dead space needles